Compounds and methods for diagnosis of tuberculosis

• US 6,338,852 B1
• Filed: 03/13/1997
• Issued: 01/15/2002
• Est. Priority Date: 09/01/1995
• Status: Expired due to Term

• Current Assignee: Corixa Corporation (GSK plc)
• Original Assignee: Corixa Corporation (GSK plc)
• Inventors: Reed, Steven G., Vedvick, Thomas S., Campos-Neto, Antonio, Skeiky, Yasir A. W., Twardzik, Daniel R., Houghton, Raymond, Dillon, Davin C.
• Primary Examiner(s): Swartz, Rodney P.
• Application Number:
  US08/818,111
• Time in Patent Office: 1,769 Days
• Field of Search: 424/9.2, 424/248.1, 435/7, 435/172.3, 435/320, 435/320.7, 530/350
• US Class Current: 424/248.1
• CPC Class Codes: A61K 39/00 Medicinal preparations containing antigens or antibodies materials for immunoassay G01N33/53
• CPC Class Codes: C07K 14/35 from Mycobacteriaceae (F)
• CPC Class Codes: C12Q 1/6883 for diseases caused by alterations of genetic material
• CPC Class Codes: G01N 33/5695 Mycobacteria

Abstract

Compounds and methods for diagnosing tuberculosis are disclosed. The compounds provided include polypeptides that contain at least one antigenic portion of one or more M. tuberculosis proteins, and DNA sequences encoding such polypeptides. Diagnostic kits containing such polypeptides or DNA sequences and a suitable detection reagent may be used for the detection of M. tuberculosis infection in patients and biological samples. Antibodies directed against such polypeptides are also provided.

Claims

1. An isolated polypeptide comprising an amino acid sequence as set forth in SEQ ID NOs:

53, 63-65, 67-73, 76-88, 90, 92, 93, 95, 97, 115-121, 123, 124, 131, or 132 or an amino acid sequence comprising an immunogenic portion of SEQ ID NOs;

53, 63-65, 67-73, 76-88, 90, 92, 93, 95, 97, 115-121, 123, 124, 131, or 132.

2. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

53 or an immunogenic portion thereof.

3. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

63 or an immunogenic portion thereof.

4. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

64 or an immunogenic portion thereof.

5. The polypeptide of claim 1, wherein the a o acid sequence is as set forth in SEQ ID NO:

65 or an immunogenic portion thereof.

6. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

67 or an immunogenic portion thereof.

7. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

68 or an immunuogenic portion thereof.

8. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

69 or an immunogenic portion thereof.

9. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

70 or an immunogenic portion thereof.

10. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

71 or an immunogenic portion thereof.

11. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

72 or an immunogenic portion thereof.

12. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

73 or an immunogenic portion thereof.

13. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

76 or an immunogenic portion thereof.

14. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

77 or an immunogenic portion thereof.

15. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

78 or an immunogenic portion thereof.

16. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

79 or an immunogenic portion thereof.

17. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

80 or an immunogenic portion thereof.

18. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

81 or an immunogenic portion thereof.

19. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

82 or an immunogenic portion thereof.

20. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

83 or an immunogenic portion thereof.

21. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

84 or an immunogenic portion thereof.

22. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

85 or an immunogenic portion thereof.

23. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

86 or an immunogenic portion thereof.

24. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

87 or an immunogenic portion thereof.

25. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

88 or an immunogenic portion thereof.

26. The polypeptide of claim 1, wherein the o acid sequence is as set forth in SEQ ID NO:

90 or an immunogenic portion thereof.

27. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

92 or an immunogenic portion thereof.

28. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

93 or an immunogenic portion thereof.

29. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

95 or an immunogenic portion thereof.

30. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

97 or an immunogenic portion thereof.

31. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

115 or an immunogenic portion thereof.

32. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

116 or an immunogenic portion thereof.

33. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

117 or an immunogenic portion thereof.

34. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

118 or an immunogenic portion thereof.

35. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

119 or an immunogenic portion thereof.

36. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

120 or an immunogenic portion thereof.

37. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

121 or an immunogenic portion thereof.

38. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

123 or an immunogenic portion thereof.

39. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

124 or an immunogenic portion thereof.

40. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

131 or an immunogenic portion thereof.

41. The polypeptide of claim 1, wherein the amino acid sequence is as set forth in SEQ ID NO:

132 or an immunogenic portion thereof.

42. A polypeptide comprising an amino acid sequence encoded by a polynucleotide sequence as set forth in SEQ ID NOs:

1, 2, 4-10, 13-43, 45, 47-52, 94, 96, 133, or 134, or a polypeptide comprising an immunogenic portion of a polypeptide encoded by SEQ ID NOs;

1, 2, 4-10, 13-43, 45, 47-52, 94, 96, 133, or 134.

43. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

1 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

1.

44. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

2 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

2.

45. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

4 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

4.

46. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

5 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

5.

47. The polypeptide of claim 42, wherein the polypeptide comprises an ammo acid sequence encoded by SEQ ID NO:

6 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

6.

48. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

7 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

7.

49. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

8 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

8.

50. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

9 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

9.

51. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

10 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

10.

52. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

13 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

13.

53. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

14 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

14.

54. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

15 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

15.

55. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

16 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

16.

56. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

17 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

17.

57. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

18 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

18.

58. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

19 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

19.

59. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

20 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

20.

60. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

21 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

21.

61. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

22 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

22.

62. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

23 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

23.

63. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

24 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

24.

64. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

25 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

25.

65. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

26 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

26.

66. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

27 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

27.

67. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

28 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

28.

68. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

29 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

29.

69. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

30 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

30.

70. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

31 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

31.

71. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

32 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

32.

72. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

33 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

33.

73. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

34 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

34.

74. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

35 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

35.

75. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

36 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

36.

76. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

37 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

37.

77. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

38 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

33.

78. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

39 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

39.

79. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

40 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

40.

80. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

41 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

41.

81. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

42 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

42.

82. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

43 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

43.

83. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

45 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

45.

84. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

47 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

47.

85. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

48 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

48.

86. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

49 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

49.

87. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

50 or an immunuogenic portion of the polypeptide encoded by SEQ ID NO;

50.

88. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

51 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

51.

89. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

52 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

52.

90. The polypeptide of claim 42, wherein tie polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

94 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

94.

91. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

96 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

96.

92. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

133 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

133.

93. The polypeptide of claim 42, wherein the polypeptide comprises an amino acid sequence encoded by SEQ ID NO:

134 or an immunogenic portion of the polypeptide encoded by SEQ ID NO;

134.